Akebia Therapeutics

+$0.08 (+3.24%) As of 3:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders.

CEO
John P. Butler
Employees
379
Headquarters
Cambridge, Massachusetts
Founded
2007

AKBA Key Statistics

Market Cap
583.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.88M
High Today
$2.56
Low Today
$2.46
Open Price
$2.50
Volume
411.47K
52 Week High
$11.92
52 Week Low
$2.09

AKBA Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure